Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Yamamoto, S. Fujiuchi, Y. Yamazaki, K. Nakanishi, A. Takeda, Y. Nishigaki, Y. Fujita, T. Fujikane (Asahikawa, Japan). Surfactant protein-A serum level is associated with disease control and hospitalisation in patients with bronchial asthma. Eur Respir J 2010; 36: Suppl. 54, 4637

Member's Comments

No comment yet.

Related content which might interest you: The relationhip between serum levels of Surfactant protein D in COPD exacerbation severity and mortality Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Serum eosinophil cationic protein as a marker of disease severity in patients with bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 51s Year: 2001 Surfactant protein-A in lung tissue obtained from patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 548s Year: 2006 Serum hyaluronidase-1 is increased in COPD exacerbations and is associated with COPD severity and outcomes Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018 Activin-A levels in sputum and serum of COPD, asthma and ACOS patients during acute exacerbation and at baseline Source: International Congress 2017 – Infection and exacerbation science Year: 2017 Inhibiting effect of influenza vaccinations on serum eotaxin level in patients with allergic bronchial asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 134s Year: 2004 Serum levels of interleukin-18 in patients affected by allergic bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 30s Year: 2002 Increased serum endotoxin levels as biomarker in acute exacerbations of COPD. Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Asthmatics with high levels of serum surfactant protein D have more severe disease Source: Eur Respir J 2016; 47:1864-1867 Year: 2016 Serum SP-A and SP-D levels in patients admitted to the hospital with acute COPD exacerbation Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016 Increased serum α1-antitrypsin level in COPD patients with predominant lung emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001 Serum ECP levels do not correlate with degree of bronchial hyperresponsiveness in patients with cough variant asthma Source: Eur Respir J 2005; 26: Suppl. 49, 584s Year: 2005 Elevated serum ECP in wheezing infants predicts the development of atopic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 192s Year: 2002 Serum interferon-gamma levels in chronic obstructive pulmonary disease and asthma patients: correlation with respiratory parameters Source: Eur Respir J 2001; 18: Suppl. 33, 75s Year: 2001 Serum YKL-40 modulation in severe asthma patients treated with Mepolizumab Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease Year: 2009 COPD: Plasma surfactant protein-D (SPD) concentration as a predictor of acute exacerbations (AE) probability Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients. Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 A study of the level of interleukin-32 in induced sputum and plasma of patients with chronic obstructive pulmonary disease and asthma Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 Plasma surfactant protein A levels are increased in smokers but do not correlate with respiratory symptoms and airway obstruction Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010